EMD-39372

Single-particle
3.27 Å
EMD-39372
3D View Gallery
Deposition: 05/03/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-39372
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8ykh summary report (pdf.gz) Map and 8ykh FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv focused on RBD and NT-108 scFv interface

EMD-39372

Single-particle
3.27 Å
EMD-39372
3D View Gallery
Deposition: 05/03/2024
Map released: 12/03/2025
Last modified: 12/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv
Fitted models: 8ykh

Deposition Authors: Anraku Y, Kita S, Onodera T, Tadokoro T, Ito S, Adachi Y, Kotaki R, Suzuki T, Hashiguchi T, Takahashi Y, Maenaka K

Structural basis for potent neutralization activity of SARS-CoV-2 antibody, NT-108
Anraku Y, Maenaka K
To Be Published